- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| RAPID DOSE THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| Mo | Rapid Dose Therapeutics issues shares to cut debt | 2 | Seeking Alpha | ||
| Sa | Rapid Dose Therapeutics Corp: Rapid Dose to issue up to 2.5 million shares for debts | 4 | Stockwatch | ||
| Sa | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Proposed Debt Settlement | 681 | Newsfile | Burlington, Ontario--(Newsfile Corp. - May 9, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces that it has agreed with certain of its creditors (the "Creditors")... ► Artikel lesen | |
| 09.04. | PTA-News: Rapid Dose Therapeutics Inc.: Update des laufenden Kooperationsprojekts mit der Fakultät für Kinesiologie - und Gesundheitsstudien an der Universität von Regina | 300 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Update des laufenden Kooperationsprojekts mit der Fakultät für Kinesiologie - und Gesundheitsstudien an der Universität von Regina
Unternehmensmitteilung... ► Artikel lesen | |
| 08.04. | Rapid Dose Therapeutics Corp: Rapid Dose advances study with NFL on concussions | 2 | Stockwatch | ||
| 08.04. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research | 402 | Newsfile | Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform... ► Artikel lesen | |
| 03.04. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics to Showcase Xylistrip, a Dental Product, at Key Tradeshows Across Canada | 435 | Newsfile | Burlington, Ontario--(Newsfile Corp. - April 3, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via... ► Artikel lesen | |
| 02.04. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 463,716 shares for note interest | 1 | Stockwatch | ||
| 02.04. | Rapid Dose Therapeutics Corp. Announces Payment in Shares for Quarterly Interest on Secured Debt and Update on Shares for Debt Settlement with Creditors | 334 | Newsfile | Burlington, Ontario--(Newsfile Corp. - April 1, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 19.02. | Rapid Dose Therapeutics Corp: Rapid Dose arranges $5-million private placement | 2 | Stockwatch | ||
| 19.02. | Rapid Dose Therapeutics announces proposed equity private placement financing | 1 | Seeking Alpha | ||
| 18.02. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing | 400 | Newsfile | Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that it plans to complete an equity private placement... ► Artikel lesen | |
| 29.01. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von QuickStrip® Nicotine | 279 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics intensiviert Zusammenarbeit mit Weltmarktführer im Bereich der oralen Nikotinprodukte - zur Vorbereitung der Markteinführung von... ► Artikel lesen | |
| 29.01. | Rapid Dose Therapeutics Corp: Rapid Dose continues deal with nicotine firm | 3 | Stockwatch | ||
| 29.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Advances Collaboration with Global Leader for Market-Ready QuickStrip(R) Nicotine in 2025 | 534 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (RDT), a Canadian biotechnology company working with an international company in oral nicotine products... ► Artikel lesen | |
| 28.01. | Rapid Dose Therapeutics Corp: Rapid Dose receives extension for debt settlement | 8 | Stockwatch | ||
| 27.01. | Rapid Dose Therapeutics receives extension to close its shares-for-debt deal | 3 | Seeking Alpha | ||
| 27.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Share Issuance in Debt Settlement with Creditors and Proposed Private Placement | 380 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 27, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated December 9, 2024... ► Artikel lesen | |
| 16.01. | Rapid Dose Therapeutics Corp.: Rapid Dose Completes Issuance of Shares as Payment of Directors' Fees | 206 | Newsfile | Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has completed its previously announced shares... ► Artikel lesen | |
| 08.01. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 430,930 shares as interest payment | 4 | Stockwatch |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 82,80 | +0,36 % | Biotech Report: Evotec fest, Biontech leichter | (shareribs.com) Frankfurt / New York 09.05.2025 - Biotech-Aktien zeigten sich im deutschen Handel uneinheitlich. Evotec legten deutlich zu. Qiagen und Biontech gaben nach. Auch an der Wall Street verlor... ► Artikel lesen | |
| CLINUVEL | 6,190 | +0,24 % | Clinuvel Pharmaceuticals Limited: CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105 | Executive summary Recruitment target of 200 vitiligo patients (Fitzpatrick skin type III-VI) in CUV105 study achievedRandomised trial, 20-week treatment protocol plus 6-month follow upStudy sites... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,323 | -2,42 % | BioNxt bezieht neues Labor bei Gen-Plus in München und erweitert Forschungsaktivitäten zur Medikamentenfreisetzung | VANCOUVER, BC / ACCESS Newswire /
13. Mai 2025 / BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE: BNXT)(OTC PINK: BNXTF)(FWB: BXT), ein auf fortschrittliche
Arzneimittelverabreichungssysteme... ► Artikel lesen | |
| ATAI LIFE SCIENCES | 1,410 | -2,35 % | ATAI Life Sciences N.V. - 10-Q, Quarterly Report | ||
| VIDAC PHARMA | 0,490 | -2,00 % | Kampf gegen Krebs als Milliarden-Chance: BioNTech, Merck, Vidac Pharma | Krebs ist die Geißel unserer Zeit. Doch in den vergangenen Jahren gab es bereits große Fortschritte. Neben deutlich verbesserten traditionellen Therapien sorgen immer wieder auch individuelle Therapieansätze... ► Artikel lesen | |
| SOL GLOBAL INVESTMENTS | 0,060 | -0,99 % | SOL Global Investments Corp.: Sol Global Announces $1M USD Strategic Investment into McQueen Labs Inc. ("MCQ Markets") for Digital Tokenization of Investment-Grade Collector Cars | Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - SOL Global Investments Corp. (CSE: SOL) (FSE: 9SB) ("SOL Global" or the "Company"), one of the first publicly traded companies focused on institutional... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 0,754 | +11,21 % | MustGrow Biologics Corp.: MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio | Saskatoon, Saskatchewan--(Newsfile Corp. - April 1, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative... ► Artikel lesen | |
| ENTHEON BIOMEDICAL CORP | 0,063 | +5,93 % | Entheon Biomedical Corp.: Entheon Announces Change of Directors | Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands... ► Artikel lesen | |
| TVARDI THERAPEUTICS | 23,150 | -0,64 % | BTIG sets $55 target on Tvardi Therapeutics stock with Buy rating | ||
| REVIVE THERAPEUTICS | 0,005 | 0,00 % | Revive Therapeutics Ltd.: Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure | TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research... ► Artikel lesen | |
| CYBIN | 5,700 | -2,56 % | CYBIN INC. - 6-K, Report of foreign issuer | ||
| ARTELO BIOSCIENCES | 0,940 | -4,71 % | Artelo Biosciences GAAP EPS of -$0.72 | ||
| AWAKN LIFE SCIENCES | 0,074 | -100,00 % | Awakn Life Sciences Corp.: Awakn Life Sciences Announces Shareholder Approval of Arrangement | Toronto, Ontario--(Newsfile Corp. - April 23, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), is pleased to announce that further to its press... ► Artikel lesen | |
| LOBE SCIENCES | 0,009 | 0,00 % | Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin | Private Placement of US$6 Million to fund additional pre-clinical research, Phase 1 and Phase 2a clinical studiesUS$20 Million additional option included in Private Placement to fund the Phase 3 clinical... ► Artikel lesen | |
| QIAGEN | 37,615 | +0,36 % | ANALYSE-FLASH: UBS belässt Qiagen auf 'Neutral' - Ziel 48 Dollar | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat Qiagen auf "Neutral" mit einem Kursziel von 48 US-Dollar belassen. Den hohen Margen im Geschäft mit Laborverbrauchsmaterialien stehe sein fehlendes... ► Artikel lesen |
RAPID DOSE THERAPEUTICS CORP gehört der Branche Biotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.